Clearing the Haze: The Emerging Anti-Fibrotic Therapy for Ocular Fibrosis Market
Ocular fibrosis, which involves the excessive scarring in the eye, is a leading cause of vision impairment and blindness. Proliferative vitreoretinopathy (PVR), glaucoma scarring, and corneal fibrosis are conditions that contribute to this incapacitating disease. The growing anti-fibrotic therapy market for ocular fibrosis is due to the dire need f